Laparoscopic Devices – Market Insights – United States

The US laparoscopic device market will expand moderately through 2033, driven by the growing demand for devices designed for robotic procedures, such as robotic trocars and hand instruments—which is supporting market expansion due to the higher prices associated with these advanced devices—as well as the continued adoption of other innovative, premium-priced technologies, such as direct energy devices, powered staplers, and 4K video laparoscopes. However, the rising use of robotic assistance will also negatively impact demand for traditional multiport laparoscopy, although the lack of additional reimbursement for robotic-assisted procedures will hinder the pace of RAS procedure volume growth to some extent. Additionally, the rising use of GLP-1 receptor agonists, which is reducing demand for bariatric surgeries, will dampen market growth to some extent.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for laparoscopic devices in the US from 2019 through 2033.

Rapidly expanding robotic-assisted procedure volumes will support overall growth in the laparoscopic device market.

How are robotic systems affecting laparoscopic and open procedure volumes?

Which competitors are currently able to market laparoscopic surgical robotic devices in the US?

What technological advancements are companies looking to offer in their laparoscopic surgical robotic devices in the coming years?

Robotic-assisted procedures will account for an increasing proportion of MIS, limiting demand for traditional laparoscopy.

Which procedure types have the highest and lowest laparoscopic technique penetration amid the growing influence of robotic surgery?

Given the rise of robotic surgery, which laparoscopic procedures are still growing, and which ones are nearing saturation?

Which technique—open or laparoscopic—is more affected by the rise of robotic surgery?

Adoption of premium-priced technologies is driving growth in the laparoscopic device market.

Which device segments will show the strongest growth in the US?

Which technologies will see increasing physician adoption during the forecast period?

GLP-1 receptor agonists have been seeing growing adoption among the US patient population in recent years.

How will the adoption of GLP-1 receptor agonists affect the US open surgery instrument market?

What impact will the rising use of GLP-1 receptor agonists have on bariatric surgery volumes?

The No Surprises Act was enacted in early 2022.

How will this impact emergency laparoscopic procedure volumes?

Significant changes were made to CPT reimbursement for anterior abdominal hernia repair.

What were the changes introduced by recent CMS coding updates for anterior abdominal hernia repair procedures?

What are the implications of altered CPT reimbursement on hernia repair procedure volumes?